De Marchi, Fabiola http://orcid.org/0000-0003-0197-1880
Berry, James D.
Chan, James
Caldwell, Sarah
Ellrodt, Amy
Scalia, Jennifer
Burke, Katherine
Fang, Ton
Clark Sisodia, Rachel
Schwamm, Lee H.
Moura, Lidia M. V. R.
Paganoni, Sabrina
Article History
Received: 5 January 2020
Revised: 20 February 2020
Accepted: 21 February 2020
First Online: 3 March 2020
Compliance with ethical standards
:
: Fabiola De Marchi: reports no disclosure. James D. Berry has been a consultant to Denali Therapeutics and has research funding from Amylyx Pharmaceuticals, Anelixis Pharmaceuticals, Biogen, Brainstorm Cell Therapeutics, Genentech, MT Pharma of America, ALS Association, ALS Finding A Cure, ALS One, EGL Foundation, and Muscular Dystrophy Association. James Chan: reports no disclosure. Sarah Caldwell: reports no disclosure. Amy Ellrodt: reports no disclosure. Jennifer Scalia: reports no disclosure. Katherine Burke: reports no disclosure. Ton Fang: reports no disclosure. Rachel Clark Sisodia: reports no disclosure. Lidia M.V.R. Moura: reports no disclosure. Lee Schwamm: reports no disclosure. Sabrina Paganoni has received research funding from the Salah Foundation, the Spastic Paraplegia Foundation, the ALS Association, ALS Finding a Cure, the American Academy of Neurology and Amylyx.
: This study has been approved by the appropriate ethics committee and has, therefore, been performed in accordance with the ethical standards (Declaration of Helsinki). In particular, this retrospective chart review and analysis was approved by the Partners Healthcare Human Research Committee.